Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer-Reference-Cited by-同舟云学术

Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer

Published:1993-01 Issue:8 Volume:29 Page:1088-1093
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Boccardo F.,Pace M.,Rubagotti A.,Guarneri D.,Decensi A.,Oneto F.,Martorana G.,Giuliani L.,Selvaggi F.,Battaglia M.,Ponti U. Delli,Petracco S.,Cortellini P.,Ziveri M.,Ferraris V.,Bruttini G.P.,Epis R.,Comeri G.,Gallo G.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Long-term results with a long-acting formulation of D-TRP-6 LH-RH in patients with prostate cancer: an Italian Prostatic Cancer Project (PONCAP) study;Boccardo;The Prostate,1987

2. Leuprolide versus diethylstilbestrol for metastatic prostate cancer;N Engl J Med,1984

3. Randomized controlled study of orchiectomy versus long-acting D-TRP6-LH-RH microcapsules in advanced prostatic carcinoma;Parmar;Lancet,1985

4. Comparison of prostatic cancer tissue dehydrotestosterone levels at the time of relapse following orchiectomy or estrogen therapy;Geller;J Urol,1984

5. Combined treatment with flutamide and (D-Trp6) LHRH ethylamide: fundamental data and 5-year clinical experience;Labrie,1987

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of serum CCL2 as prognostic biomarker in prostate cancer: a long-term follow-up study;Japanese Journal of Clinical Oncology;2022-06-20

2. A review of clinical evidence to assess differences in efficacy and safety of luteinizing hormone–releasing hormone (LHRH) agonist (goserelin) and LHRH antagonist (degarelix);Indian Journal of Cancer;2022

3. Efficacy and Safety of Non-Steroidal Anti-Androgens in Patients with Metastatic Prostate Cancer: Meta-Analysis of Randomized Controlled Trials;Reviews on Recent Clinical Trials;2020-02-14

4. Efficacy and Safety of Combined Androgen Blockade with Antiandrogen for Advanced Prostate Cancer;Current Oncology;2019-02-01

5. Both High and Low Serum Total Testosterone Levels Indicate Poor Prognosis in Patients with Prostate Cancer;Anticancer Research;2017-10-03